LiveActive security incident?Get immediate response
CVE Record

CVE-2014-5432: Baxter SIGMA Spectrum Infusion System version 6.05 (model 35700BAX) with wireless battery module (WBM) vers...

Baxter SIGMA Spectrum Infusion System version 6.05 (model 35700BAX) with wireless battery module (WBM) version 16 is remotely accessible via Port 22/SSH without authentication. A remote attacker may be able to make unauthorized configuration changes to the WBM, as well as issue commands to access account credentials and shared keys. Baxter asserts that this vulnerability only allows access to features and functionality on the WBM and that the SIGMA Spectrum infusion pump cannot be controlled from the WBM. Baxter has released a new version of the SIGMA Spectrum Infusion System, Version 8, which incorporates hardware and software changes.

UnknownCVSS not scoredNot KEV-listedUpdated
Glexia's TakeAutomated analysishigh

Security readout for executives and security teams

Plain-English summary

This issue affects a specific Baxter SIGMA Spectrum infusion setup where the wireless battery module can be reached over SSH without authentication. An attacker with network access could change WBM configuration or access credentials and shared keys. Baxter states the infusion pump itself cannot be controlled through the WBM.

Executive priority

Treat this as a high-priority medical device exposure review, especially in facilities still running older SIGMA Spectrum systems. The evidence does not show pump control, but unauthenticated access to module configuration and credentials can create operational and network-security risk.

Technical view

CVE-2014-5432 describes unauthenticated remote access to Port 22/SSH on Baxter SIGMA Spectrum Infusion System v6.05 model 35700BAX with WBM v16. Reported impact is limited to WBM functionality, including unauthorized configuration changes and access to credentials or shared keys. Baxter released SIGMA Spectrum Version 8 with hardware and software changes.

Likely exposure

Exposure appears limited to SIGMA Spectrum Infusion System v6.05, model 35700BAX, with WBM version 16, where Port 22/SSH is reachable. Organizations without this exact model, version, and WBM combination are not shown affected by the supplied sources.

Exploitation context

The source bundle does not show CISA KEV listing or active exploitation. The weakness is still serious because the described access is remote and unauthenticated, but the available evidence does not support claims of public exploitation or pump-control capability.

Researcher notes

Do not generalize this CVE beyond the named SIGMA Spectrum v6.05 model 35700BAX with WBM v16. The supplied record lacks CVSS detail and active exploitation evidence. Baxter’s stated impact boundary is WBM-only functionality, not infusion pump control.

Mitigation direction

  • Confirm whether affected devices can be upgraded to SIGMA Spectrum Version 8.
  • Review Baxter and CISA advisory guidance for device-specific remediation.
  • Restrict network reachability to WBM SSH services while remediation is planned.
  • Remove affected devices from untrusted or broadly reachable networks.
  • Coordinate remediation with clinical engineering before operational changes.

Validation and detection

  • Inventory SIGMA Spectrum devices by model, software version, and WBM version.
  • Identify whether Port 22/SSH is reachable to any WBM from hospital networks.
  • Verify whether any affected v6.05 systems remain in service.
  • Check whether devices have been migrated to SIGMA Spectrum Version 8.
  • Document compensating controls for any device awaiting vendor-supported remediation.
Prepared
Confidence
medium
Sources
3

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cwe · low confidence lookup

CWE-592: Exact CWE lookup

Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.

Open ATT&CK lookup
cve · low confidence lookup

CVE-2014-5432 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Unknown
CVSS
Not scored
Known Exploited
No
Published
Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

0CVSS vectors
0Timeline events
0ADP providers
2Source links

CVSS and timeline data

No CVSS vectors or timeline events were available in the normalized CVE source material.

Source materials

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
BaxterSIGMA Spectrum Infusion System6.05 (model 35700BAX) with wireless battery module (WBM) version 16.Listed
Weakness

CWE details

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.

CWE-592 · source CWE mapping

DEPRECATED: Authentication Bypass Issues

DEPRECATED: Authentication Bypass Issues represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.